INFECTION

Deadly E.Coli outbreak in Germany spreads panic worldwide - what you should know

The recent E.coli outbreak in Germany, which killed 11 people, has spread panic and concern throughout Europe and the world. In what is considered the largest E.coli outbreak in Germany, the origin of the recent event is still under investigation. Countries such as Spain and Sweden have been linked to the transport of contaminated cucumbers. Precautions has been taken into account as vegetables are under serious testing and selected kinds may be banned from entering certain countries. Here is...

Researchers working on ‘digital ants’ to flush out virus in computer networks

Wake Forest University, North Carolina, professor of Computer Science Errin Fulp, and his team of scientists at Pacific Northwest National Laboratory (PNNL) in Richland, Washington, are developing an army of ‘digital ants’ which will be set loose into the power grid of a computer to discover viruses in the system, a report in the university website said.
More news

Superbug Bacteria Seen In Canadian Bedbugs

Bloodsucking bedbugs are creepier now compared to before. A report released by the US Centers for Disease Control and Prevention tells that bedbugs found in a poor place in Vancouver, Canada carries drug-resistant staph bacteria. It is potentially dangerous as drugs could not treat the staph that the bedbugs carry.
The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland

FDA warns four hand sanitizer companies on false claims

The U.S. Food and Drug Administration (FDA) said on Wednesday it issued four warning letters to companies that manufacture and market over-the-counter (OTC) drug products, including hand sanitizers, that claim to prevent infection from methicillin-resistant Staphylococcus aureus bacteria (MRSA).
The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland

FDA OKs new treatment for large brain aneurysms

The U.S. Food and Drug Administration (FDA) has approved a new treatment system manufactured by Neurovasx Inc. for large brain aneurysms. Maple Grove-based Neurovasx's cPAX Aneurysm Treatment System is for surgery on brain aneurysms that are difficult to manage because of their size and shape.

Cepheid's bacteria infection test gets FDA OK

The U.S. Food and Drug Administration (FDA) has approved molecular diagnostics company Cepheid (NASDAQ: CPHD)'s test designed to detect the toxin associated with a common bacterial infection that can cause diarrhea and other serious intestinal conditions and death in severe cases.
The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland

FDA OK's device to treat brain aneurysms

The U.S. Food and Drug Administration (FDA) cleared a new device, manufactured by California-based ev3, to treat brain aneurysms without performing open surgery.
IBTimes Logo

Cubist Pharma Shares Hit New High

Shares of Cubist Pharmaceuticals Inc. (CBST) touched a new 52-week high of $30.02 on Wednesday morning. Optimer Pharmaceuticals Inc. (OPTR) said it has entered an exclusive two-year co-promotion agreement with Cubist to market Dificid in the U.S.
IBTimes Logo

Cyber vulnerability in focus as targeted attacks poised to rise

Targeted attacks, including attacks on leading mobile platforms, are set to rise further in future, security software maker Symantec said on Tuesday. Targeted cyber attacks are more complex and challenging but the returns are also higher, prompting cyber criminal to launch more of this kind in future, a security strategist at Symantec told Reuters.

Pre-Market NASDAQ Movers (MSSR, VVUS, OREX, CIGX, OPTR, OVTI, DEPO, AMTD, LOGI, CHKP)

The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, VIVUS, Orexigen Therapeutics, Star Scientific, and Optimer Pharmaceuticals. The top pre-market NASDAQ Stock Market losers are: OmniVision Technologies, DepoMed, TD AMERITRADE Holding, Logitech International, and Check Point Software Technologies.
Vertex Pharmaceuticals

Vertex Pharma Shares Hit New High Again

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) reported positive interim results on March 2 from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection. The shares of the drugmaker touched a new 52-week high of $51.10 on Friday.
Vertex Pharmaceuticals

Vertex Pharma stock hits new high again on positive study results

Shares of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) touched a new 52-week high of $50.83 on Thursday. The company announced positive interim results on Wednesday from a Phase 2 two-part study of 'telaprevir' combination therapy for treatment of hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.

Pages

  • Promoted in South Africa

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.